Showing results (171-180 of 232) with videos related to

Sort By:
Pageof 24
Clinical Hematology International|October 1, 2021
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?Anna Suska, David H Vesole, Jorge J Castillo, et al.
Mediators of Inflammation|November 4, 2020
Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple MyelomaMałgorzata Banaszkiewicz, Jolanta Małyszko, Krzysztof Batko, et al.
Leukemia & Lymphoma|January 18, 2017
Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study GroupNorbert Grzasko, Roman Hajek, Marek Hus, et al.
The Oncologist|February 28, 2016
The Changing Landscape of Smoldering Multiple Myeloma: A European PerspectiveJo Caers, Carlos Fernández de Larrea, Xavier Leleu, et al.
Leukemia & Lymphoma|November 26, 2021
Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomesLaurent Garderet, Mohammad Al Hariri, Joanna Wasielica-Poslednik, et al.
Journal of Clinical Medicine|February 25, 2023
A Stepwise Screening Protocol for Multiple MyelomaMarta Morawska, Jadwiga Dwilewicz-Trojaczek, Tomasz Stompór, et al.
Archives of Medical Science : AMS|February 19, 2025
Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study GroupAnna Waszczuk-Gajda, David H Vesole, Jolanta Małyszko, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|September 15, 2017
Biomarkers in Immunoglobulin Light Chain AmyloidosisZ Kufová, T Sevcikova, K Growkova, et al.
Haematologica|August 30, 2023
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE studyLuděk Pour, Monika Szarejko, Jelena Bila, et al.
Annals of Hematology|August 3, 2017
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control studyArtur Jurczyszyn, Alessandro Gozzetti, Joanna Gdula-Argasińska, et al.
Pageof 24